AJ11-Synthesis of Cyclic Peptide NPC86
Key Takeaways
- Full and open competition - all businesses eligible to bid
- Work to be performed in TAMPA, FL
- Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Contract Details
- Notice ID
- 36C24826Q0987
- Opportunity Type
- Special Notice
- Sub-Agency
- VETERANS AFFAIRS, DEPARTMENT OF
- Office
- 248-NETWORK CONTRACT OFFICE 8 (36C248)
- Posted Date
- Thursday, July 23, 2026
- Response Deadline
- Tuesday, July 28, 2026
- PSC Code
- AJ11
- Set-Aside
- Full & Open Competition
- Place of Performance
- TAMPA, FL, 33637
- Status
- Active
Description
Special Notice Special Notice Page 4 of 4 Non-GMP Synthesis of NP-C86 (Cyclic Peptide) James A. Haley VA Medical Center, 13000 Bruce B. Downs Blvd., Tampa, Florida 33612, intends to solicit sole source to Curia Global Inc., for the NPC86 which is a new drug designed to alleviate metabolic diseases such as T2D and neurodegenerative diseases. The chemistry to synthesize the drug is highly specialized and uses the solid state synthesis method. The target is to synthesize 2 grams of NPC86 which is acyclic peptide. Curia will use Solid Phase Peptide Synthesis (SPPS) for this peptide, initiating the synthesis on Rink amide resin. This approach will yield an amide functionality at the C-terminal upon cleavage. The target specification for the final compound is 95% purity by HPLC (area%, non-valid
Why This Opportunity Matters
VETERANS AFFAIRS, DEPARTMENT OF is seeking responses for research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) in TAMPA, FL.
Similar Opportunities
Browse Related
Looking for more opportunities?
Browse our full directory of government contracts
